NBTX
Price:
$21.82
Market Cap:
$895.84M
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with LianBio to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. The company was incorporated in 2003 and is headquartered in Paris, France.
Industry
Biotechnology
IPO Date
2020-12-11
Stock Exchange
NASDAQ
Ticker
NBTX
According to Nanobiotix S.A.’s latest financial reports and current stock price. The company's current ROE is 155.77%. This represents a change of -26.92% compared to the average of 213.14% of the last 4 quarters.
The mean historical ROE of Nanobiotix S.A. over the last ten years is 423.47%. The current 155.77% ROE has changed -63.22% with respect to the historical average. Over the past ten years (40 quarters), NBTX's ROE was at its highest in in the December 2019 quarter at 1.32%. The ROE was at its lowest in in the June 2022 quarter at -1522.65%.
Average
423.47%
Median
-53.63%
Minimum
-213.05%
Maximum
2.50%
Discovering the peaks and valleys of Nanobiotix S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 921.33%
Maximum Annual ROE = 2.50%
Minimum Annual Increase = -1272.04%
Minimum Annual ROE = -213.05%
| Year | ROE | Change |
|---|---|---|
| 2024 | 103.70% | -95.19% |
| 2023 | 2.15% | 921.33% |
| 2022 | 210.91% | -219.77% |
| 2021 | -176.09% | 268.87% |
| 2020 | -47.74% | -101.91% |
| 2019 | 2.50% | -1272.04% |
| 2018 | -213.05% | 257.94% |
| 2017 | -59.52% | -52.67% |
| 2016 | -125.76% | 15.47% |
| 2015 | -108.92% | 245.50% |
The current ROE of Nanobiotix S.A. (NBTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
822.90%
5-year avg
448.97%
10-year avg
423.47%
Nanobiotix S.A.’s ROE is greater than GH Research PLC (-16.71%), greater than ARS Pharmaceuticals, Inc. (-38.77%), greater than Savara Inc. (-69.05%), greater than Tyra Biosciences, Inc. (-31.80%), greater than Rezolute, Inc. (-62.82%), greater than Kura Oncology, Inc. (-65.42%), greater than Arbutus Biopharma Corporation (-50.20%), less than ProKidney Corp. (11.01%), greater than LENZ Therapeutics, Inc. (-25.63%), greater than EyePoint Pharmaceuticals, Inc. (-76.13%),
| Company | ROE | Market cap |
|---|---|---|
| -16.71% | $952.15M | |
| -38.77% | $978.98M | |
| -69.05% | $1.30B | |
| -31.80% | $1.18B | |
| -62.82% | $899.46M | |
| -65.42% | $1.04B | |
| -50.20% | $847.53M | |
| 11.01% | $723.22M | |
| -25.63% | $778.71M | |
| -76.13% | $1.15B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nanobiotix S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nanobiotix S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Nanobiotix S.A.'s ROE?
How is the ROE calculated for Nanobiotix S.A. (NBTX)?
What is the highest ROE for Nanobiotix S.A. (NBTX)?
What is the 3-year average ROE for Nanobiotix S.A. (NBTX)?
What is the 5-year average ROE for Nanobiotix S.A. (NBTX)?
How does the current ROE for Nanobiotix S.A. (NBTX) compare to its historical average?